Holen Sie sich die Stockscreener-App
249.72
0.14%
0.53
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RMD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Resmed Inc Aktie (RMD) Neueste Nachrichten
The Truth About ResMed Inc: Sleep Tech Darling or Overhyped Dinosaur? - AD HOC NEWS
ResMed stock in focus: sleep-tech leader tests investor conviction after choppy start to the year - AD HOC NEWS
Global Sleep Tech Devices Market Poised for Strong Growth at a CAGR of ~17% by 2032, Driven by Rising Sleep Disorder Prevalence | DelveInsight - GlobeNewswire Inc.
Asset Management One Co. Ltd. Raises Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Updates CDI and Share Structure for December 2025 - TipRanks
Insider Sell: Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) - GuruFocus
ResMed Officer Brett Sandercock Discloses Planned Sale of 1,000 Shares Under Trading Plan - TipRanks
ResMed (NYSE:RMD) General Counsel Michael Rider Sells 50 Shares - MarketBeat
ResMed Q2 2026 Earnings Preview: EPS Growth Forecast & Analyst Rating | BarchartNews and Statistics - IndexBox
ResMed Inc. $RMD Shares Sold by TriaGen Wealth Management LLC - MarketBeat
What You Need to Know Ahead of ResMed's Earnings Release - Yahoo Finance
ResMed Inc.: How a Sleep-Tech Powerhouse Is Turning Data, Devices and Chronic Care Into a Platform P - AD HOC NEWS
Geopolitics Watch: Is ResMed Inc Common Stock RMEA stock overpriced at current multiplesWeekly Profit Summary & Weekly Return Optimization Plans - moha.gov.vn
ResMed Inc Reports Changes in CHESS Depositary Interests and Securities - MSN
ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 69% of the company - simplywall.st
ResMed Inc. $RMD Shares Sold by Inspire Investing LLC - MarketBeat
Here's What ResMed's (NYSE:RMD) Strong Returns On Capital Mean - Yahoo Finance
ResMed Inc. Reports Changes in Beneficial Ownership - MSN
The Truth About ResMed Inc: Is This Sleep Tech Stock Quietly Going Viral? - AD HOC NEWS
ResMed (RMD) Product Pipeline Analysis Report 2025 – ResearchAndMarkets.com - The AI Journal
ResMed (RMD) Product Pipeline Analysis Report 2025ResearchAndMarkets.com - Bluefield Daily Telegraph
Is ResMed CDI (ASX:RMD) Still Shaping Value For Investors? - Kalkine Media
Ethic Inc. Raises Stock Holdings in ResMed Inc. $RMD - MarketBeat
Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now? - The Globe and Mail
3 Stocks Likely to Gain From Rising HSA Contribution & Medicare Premium - TradingView — Track All Markets
ResMed Inc announces proposed sale of securities by director - MSN
The Truth About ResMed Inc.: Is This Sleep Tech Stock the Next Viral Gamechanger or Just Hype? - AD HOC NEWS
ResMed Stock Breathes Easier as Sleep-Apnea Giant Outpaces the Market - AD HOC NEWS
ResMed Inc. $RMD Stock Holdings Raised by Pacer Advisors Inc. - MarketBeat
Why analysts maintain buy rating on ResMed Inc. (RME) stockGlobal Market Influence & Big Gains Small Capital - bollywoodhelpline.com
ResMed Officer Plans Further Share Sale Under Rule 144 - MSN
ResMed Inc. (NYSE:RMD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Voya Investment Management LLC Has $8.97 Million Position in ResMed Inc. $RMD - MarketBeat
Swedbank AB Increases Stock Position in ResMed Inc. $RMD - MarketBeat
Is ResMed stock underperforming the S&P 500? - MSN
Why ResMed (RMD) is a Top Growth Stock for the Long-Term - Yahoo Finance
OLD National Bancorp IN Increases Stock Holdings in ResMed Inc. $RMD - MarketBeat
Patton Fund Management Inc. Has $265,000 Stock Holdings in ResMed Inc. $RMD - MarketBeat
Confluence Investment Management LLC Sells 4,405 Shares of ResMed Inc. $RMD - MarketBeat
Thrivent Financial for Lutherans Acquires 5,212 Shares of ResMed Inc. $RMD - MarketBeat
The Bull Case For ResMed (RMD) Could Change Following FDA-Cleared AI Smart Comfort CPAP Feature - Sahm
Texas Permanent School Fund Corp Sells 5,560 Shares of ResMed Inc. $RMD - MarketBeat
Assenagon Asset Management S.A. Sells 5,635 Shares of ResMed Inc. $RMD - MarketBeat
Will ResMed Inc. (Common Stock) (RMEA) stock beat revenue estimatesPortfolio Performance Report & Intraday High Probability Alerts - ulpravda.ru
Technical Analysis: Will ResMed Inc. stock gain from strong economyTrend Reversal & Weekly High Return Stock Forecasts - ulpravda.ru
Is ResMed Inc. stock attractive for long term wealth buildingJuly 2025 Price Swings & Real-Time Volume Analysis - DonanımHaber
Will ResMed Inc. stock deliver better than expected guidanceJuly 2025 Movers & Long Hold Capital Preservation Tips - DonanımHaber
Resmed Inc Officer Plans Sale of Common Stock - MSN
Will ResMed Inc. stock attract more institutional investorsMarket Volume Report & Real-Time Volume Triggers - Улправда
Will ResMed Inc. stock benefit from automationQuarterly Trade Review & Growth-Oriented Investment Plans - DonanımHaber
Why ResMed Inc. stock is a value investor pickJuly 2025 Short Interest & Smart Money Movement Tracker - Улправда
ResMed Inc. $RMD Shares Acquired by Addenda Capital Inc. - MarketBeat
Healthcare Equipment Focus as ResMed Appears in ASX 100 Landscape - Kalkine Media
Is ResMed Inc. stock in correction or buying zoneJuly 2025 Setups & Daily Technical Forecast Reports - Улправда
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Two Resmed leaders take the J.P. Morgan Healthcare Conference stage - Stock Titan
ResMed (FRA:RMEA) EV-to-OCF : 17.84 (As of Dec. 18, 2025) - GuruFocus
Is It Too Late to Consider ResMed After Weight Loss Drug Concerns and DCF Outlook? - Sahm
Stifel Maintains ResMed (RMD) Hold Recommendation - Nasdaq
Will ResMed Inc. (RME) stock outperform Dow Jones2025 Momentum Check & Community Trade Idea Sharing Platform - Улправда
Stifel Nicolaus Adjusts ResMed Price Target to $260 From $270, Maintains Hold Rating - marketscreener.com
1.04%
1.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):